mynth
04/2022Majority

Montefiore Investment & Pléiade Investissement take majority stake in Generix Group

FRANCE Software / Supply Chain & Ops EV €100–350M

Context

Montefiore Investment has entered into exclusive negotiations to take Generix Group private through a public tender offer. The transaction is structured via a new acquisition holding company, New Gen, in partnership with the historical reference shareholder Pléiade Investissement (which has held a stake since 2002) and the company's management. The strategic rationale for the deal is to accelerate Generix's transition to a full SaaS model and drive its international expansion outside of its core French market. The transition will be accompanied by a leadership change, with Aïda Collette-Sène succeeding Jean-Charles Deconninck as head of the executive board. By delisting from Euronext (Compartment C), the company aims to pursue its long-term growth projects away from the short-term pressures of the public markets.

Generix Group, which reported an EBITDA margin of [members only] in 2021, is valued in this transaction at an EV/EBITDA multiple of 15x–25x.

-> Deep-dive in TMT (Tech, Media, Telecom) market trends

Target

Generix Group is a French software company specializing in collaborative supply chain and retail solutions. The organization provides a comprehensive suite of cloud-based services designed to optimize physical flows, digital processes, and customer experience for industrial players, logistics providers, and retailers. Its technology portfolio includes Warehouse Management Systems (WMS), Transport Management Systems (TMS), and EDI (Electronic Data Interchange) platforms. As of its 2021-2022 fiscal year, the entity generated 41% of its revenue through a SaaS subscription model, with the remainder coming from traditional licenses, maintenance, and consulting services. Headquartered in France, which accounts for over 55% of its turnover, the firm also maintains international operations, including a 7% revenue exposure to Russia. The group supports digital transformation by enabling seamless integration between supply chain actors and enhancing real-time data visibility across global distribution networks.

Ent. Value

€100–350M

Equity Value

[members only]

Multiples

EV / Revenue

2x–6x

EV / EBITDA

15x–25x

EV / EBIT

[members only]

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2021
€50–100M
€5–25M
[members only]
2020
€50–100M
€5–25M
[members only]

Other operations with Montefiore Investment / Pléiade Investissement

Other operations with Montefiore Investment / Pléiade Investissement
DateAcquirerTargetCountrySector
01/2026MONTEFIORE INVESTMENT / ACTIVA CAPITALARCHE MC2FRANCEHealthcare
08/2025MONTEFIORE INVESTMENT / CERES INDUSTRIES CAPITAL / CFJ (COMPAGNIE FINANCIÈRE JOUSSET)KARAVELFRANCETour Operators
10/2024MONTEFIORE INVESTMENTDEMENEGOITALYOphthalmology
10/2023MONTEFIORE INVESTMENT / BNP PARIBAS DEVELOPPEMENT / SOCIETE GENERALE CAPITAL PARTENAIRES / CARVEST (CRÉDIT AGRICOLE RÉGIONS INVESTISSEMENT)KOESIOFRANCEMSP (Managed Services)
05/2023MONTEFIORE INVESTMENTEXO GROUPITALYFinishing Works
10/2021MONTEFIORE INVESTMENTNGEFRANCEPublic Works
10/2020MONTEFIORE INVESTMENTGROUPE OPENFRANCEConsulting & Integration
07/2016MONTEFIORE INVESTMENTISABEL MARANTFRANCEFashion & Apparel
11/2007MONTEFIORE INVESTMENTASMODEE GROUPFRANCEConsumer Products
02/2006MONTEFIORE INVESTMENTHOMAIR VACANCESFRANCEHotels & Accommodation

Similar deals in Software

Similar deals in Software
DateAcquirerTargetCountrySector
05/2022W.A.G PAYMENT SOLUTIONSWEBEYE TELEMATICSHUNGARYAutomotive
05/2022CT ENGINEERINGINFODREAMFRANCESupply Chain & Ops
04/2022SOGELINKFOCUS SOFTWARENORWAYEngineering & Design Software
04/2022SOGELINKLOCATIQSNETHERLANDSEngineering & Design Software
04/2022PATIENT SQUARE CAPITALSOC TELEMEDUNITED STATESHealthcare
04/2022VERVEAXESINMOTIONSPAINGaming & Consumer Apps
03/2022CVCRGI GROUPITALYFinancial Services / Banking
03/2022ALBAREST / BPIFRANCEMASA GROUPFRANCEDefense & Aerospace
03/2022APAX PARTNERSALCUMUSUNITED KINGDOMIndustry-Specific Software
03/2022BPIFRANCE / EURAZEODOCTOLIBFRANCEHealthcare

REFERENCES

Valuation range: EV €100–350M

Revenue range: €50–100M

EBITDA range: €5–25M

EV/Revenue range: 2x - 6x

EV/EBITDA range: 15x - 25x

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Generix Group by Montefiore Investment / Pléiade Investissement are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

FAQ

What transaction does this page cover?

This page covers the acquisition of a majority stake in Generix Group, a French company specialised in Supply Chain & Ops, by Montefiore Investment and Pléiade Investissement in 2022.

How was the acquisition of Generix Group by Montefiore Investment valued, and what multiples were paid?

mynth displays the transaction’s enterprise value within the €100–350M band, its EV/EBITDA multiple within the 15x - 25x range, and its EV/revenue multiple within the 2x - 6x range. Exact figures are available to members.

What were Generix Group’s revenue and EBITDA at the time of the deal?

At the time of the transaction, Generix Group generated annual revenue estimated in the €50–100M range and EBITDA in the €5–25M bracket (FY 2021). Detailed financial figures are available to members.

What sources support the information on this transaction?

Data on this transaction was compiled from the official corporate announcement published by the parties, combined with independent reporting from specialized financial and M&A publications.

What is mynth?

mynth is the first free M&A database dedicated to Small & Mid-Cap transactions. We centralize Enterprise Values, revenue multiples, EBITDA multiples and transaction financials that are typically locked behind five-figure subscriptions on platforms like Capital IQ or Mergermarket. On mynth, searching and browsing deals is completely free. Our mission is simple: make professional-grade valuation intelligence accessible to every M&A advisor, independent consultant, Private Equity professional and student, without the burden of expensive annual licenses.